Physician profile
William S Cornish
NPI 1013993880
$645.90
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $138 · 2021: $152 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $140.88 | 2019-2021 | |
| Abbvie INC. | $124.20 | 2019 | |
| Lilly USA, LLC | $123.24 | 2021-2024 | Mounjaro |
| Amgen INC. | $68.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $53.80 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $48.90 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.69 | 2019 | |
| Janssen Biotech, INC. | $19.31 | 2019 | |
| Sanofi Pasteur INC. | $18.30 | 2019 | |
| Mylan Specialty L.P. | $15.10 | 2021 | |
| Glaxosmithkline, LLC. | $12.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cornish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.